HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

878.487

+2.5720.29%

Number of Gainers:6

Number of Losers:9

Number of Flat:2

PE:- -

High:890.706

Open:878.139

Low:871.523

Close:875.916

Volume:229.26M

Turnover:1.66B

Market Cap:594.29B

Float Cap:491.83B

Loading ...

CSPC Pharmaceutical Gets Breakthrough Therapy Designation for Lung Cancer Drug

MT Newswires Live

Cspc Pharmaceutical Says Sys6010 Granted Breakthrough Therapy Designation by NMPA

CSPC Pharma's Novel Drug SYS 6010 Receives Breakthrough Therapy Designation in China for Advanced Non-Small Cell Lung Cancer

CSPC Pharmaceutical - Sys6010 Granted Breakthrough Therapy Designation by Nmpa in China for Nsclc

THOMSON REUTERS

GENFLEET-B Buys Back 50,000 Shares for HK$1.30 Million on September 15

Fosun Pharma Spends HK$22.07 Million on Share Buyback on September 15

CSPC Pharmaceutical Group Stock Sheds 1.9% in Hong Kong, Underperforms Competitors

Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong

Alibaba Health Information Technology Stock Slides 2.5% in Hong Kong

Shares of ALEBUND-B Surge Over 17% in Afternoon Trading on US FDA Approval for IgA Nephropathy Drug Candidate

Channel Edge Fades, Active Research Lags: Who Can Fill ICBC Credit Suisse's Equity Gap?

Hong Kong Stock Flash | TYK Medicines-B (02410) Surges Over 10% as Major Shareholder's Buyback Lifts Sentiment, Following Key Drug Approval

GENFLEET-B (02595) Presents Encouraging Phase II Monotherapy Results for Oral KRAS G12D Inhibitor in Pretreated NSCLC at WCLC 2026

Record WCLC Data From Chinese Innovators Signals Clear Recovery for CRO/CDMO Sector, Wall Street Takes Notice

National Healthcare Security Administration Releases Roster of Pharmaceutical Firms With 'Severe' and 'Extremely Severe' Credit Violations

Fosun Pharma Spends HK$24.7 Million Buying Back 1.455 Million Shares on September 14

Market Trading Volume Shrinks as Indices Retreat; Pharma and Banking Sectors Provide Support | Huabao Fund Daily Briefing (September 14, 2026)

CSPC Pharmaceutical Group Stock Rallies 1.8% in Hong Kong

BYD Electronic (International) Stock Slides 2.3% in Hong Kong

Sino Biopharmaceutical Stock Advances 4.3% in Hong Kong, Outperforms Competitors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BK1515/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":878.48724,"timestamp":1789546124622,"preClose":875.9157,"halted":0,"volume":229256212,"delay":0,"changeRate":0.002936,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":2.571533,"latestTime":"09-16 16:00:00","open":878.13885,"high":890.7062,"low":871.5229,"amount":1664552354,"amplitude":0.021901,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789608600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789522200000,1789531200000],[1789534800000,1789545600000]],"pbRate":1.316272,"peRate":17.057675,"turnoverRate":0.002983,"increases":7,"decrements":9,"flats":1,"marketCap":594294408000,"floatMarketCap":491832141504},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":890.7062,"amplitude":0.021901,"preClose":875.9157,"low":871.5229,"pbRate":"1.316272","latestPrice":878.48724,"volume":229256212,"delay":0,"open":878.13885,"prevYearClose":1190.107,"prevWeekClose":878.789,"prevMonthClose":925.265,"prevQuarterClose":802.777,"fiveDayClose":912.778,"twentyDayClose":905.419,"sixtyDayClose":815.098,"secType":"PLATE","market":"HK","turnoverRate":0.002983,"peRate":17.057675,"marketCap":594294408000,"floatMarketCap":491832141504,"timestamp":1789546124622,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":6,"down":9,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667644981","title":"CSPC Pharmaceutical Gets Breakthrough Therapy Designation for Lung Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2667644981","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667644981?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:49","pubTimestamp":1789472968,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group  said its SYS6010 drug has received Breakthrough Therapy Designation from China's National Medical Products Administration.The designation covers the treatment of recurrent or metastatic non-squamous non-small cell lung cancer with actionable genomic alteration-negative status in patients whose disease has progressed after prior immunotherapy and platinum-based chemotherapy, according to a Tuesday Hong Kong exchange filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1807302812.USD","LU1993786604.SGD","LU1008478684.HKD","LU0072913022.USD","LU1226287792.SGD","LU1226288170.HKD","SG9999004220.SGD","IE00BZ08YT58.USD","01093","LU0315179316.USD","KURE","LU1813983027.USD","IE00BZ08YR35.GBP","IE0008369823.USD","IE00B031HY20.USD","LU2039709279.SGD","LU1328277881.USD","LU1951186391.HKD","IE00B543WZ88.USD","HK0000165453.HKD","IE00BZ08YS42.EUR","BK1515","LU1152091754.HKD","LU1152091168.USD","LU0880133367.SGD","BK1521","IE0008368742.USD","LU1960683339.HKD","LU0501845795.SGD","BK1191","LU0067412154.USD","IE00B5MMRT66.SGD","LU1226287875.USD","LU0326950275.SGD","LU0140636845.USD","LU1226287529.USD","LU0314109678.HKD","LU1226288253.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667646466","title":"Cspc Pharmaceutical Says Sys6010 Granted Breakthrough Therapy Designation by NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2667646466","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667646466?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:28","pubTimestamp":1789468089,"startTime":"0","endTime":"0","summary":"Sept 15 (Reuters) - CSPC PHARMACEUTICAL <1093.HK>::*SYS6010 GRANTED BREAKTHROUGH THERAPY DESIGNATION BY NMPA IN CHINA FOR NSCLC*Further company coverage: 1093.HK* ((Reuters.Briefs@thomsonreuters.com;)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nRSDbrrGqm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008368742.USD","IE00BZ08YR35.GBP","IE00B031HY20.USD","LU0072913022.USD","LU1951186391.HKD","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","LU0315179316.USD","LU0314109678.HKD","SG9999004220.SGD","LU0067412154.USD","LU1226288253.USD","LU1226287529.USD","LU1152091754.HKD","LU1226287792.SGD","LU1152091168.USD","LU0501845795.SGD","BK1191","BK1521","IE0008369823.USD","LU1328277881.USD","LU0326950275.SGD","LU1960683339.HKD","LU1807302812.USD","LU0140636845.USD","LU2039709279.SGD","01093","LU1008478684.HKD","LU1226287875.USD","KURE","LU1813983027.USD","IE00B5MMRT66.SGD","LU1226288170.HKD","LU1993786604.SGD","LU0880133367.SGD","HK0000165453.HKD","IE00B543WZ88.USD","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167369366","title":"CSPC Pharma's Novel Drug SYS 6010 Receives Breakthrough Therapy Designation in China for Advanced Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1167369366","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167369366?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:10","pubTimestamp":1789467046,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that its innovative drug candidate, SYS 6010, has been included in the Breakthrough Therapy Designation list by China's National Medical Products Administration...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1521","01093","LU1226288253.USD","LU0326950275.SGD","LU1226288170.HKD","LU1993786604.SGD","LU1226287875.USD","IE00BZ08YT58.USD","LU2039709279.SGD","LU1152091168.USD","IE00B5MMRT66.SGD","LU1152091754.HKD","LU1807302812.USD","LU0314109678.HKD","IE0008369823.USD","IE00B031HY20.USD","LU0072913022.USD","LU1813983027.USD","LU1008478684.HKD","IE00B543WZ88.USD","LU1226287792.SGD","LU0501845795.SGD","LU1328277881.USD","LU0315179316.USD","IE00BZ08YR35.GBP","BK1515","HK0000165453.HKD","LU1226287529.USD","IE00BZ08YS42.EUR","LU0067412154.USD","SG9999004220.SGD","KURE","LU1960683339.HKD","IE0008368742.USD","LU1951186391.HKD","LU0140636845.USD","LU0880133367.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667645268","title":"CSPC Pharmaceutical - Sys6010 Granted Breakthrough Therapy Designation by Nmpa in China for Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2667645268","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667645268?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:02","pubTimestamp":1789466529,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570BT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1515","LU1807302812.USD","IE00BZ08YS42.EUR","LU1008478684.HKD","LU1226288253.USD","KURE","LU1951186391.HKD","LU1226287792.SGD","LU1328277881.USD","LU2039709279.SGD","IE0008369823.USD","BK1521","LU0326950275.SGD","LU1993786604.SGD","01093","LU1152091168.USD","HK0000165453.HKD","IE00BZ08YR35.GBP","LU0072913022.USD","LU1226287875.USD","LU0315179316.USD","LU1960683339.HKD","IE00BZ08YT58.USD","IE00B031HY20.USD","IE00B5MMRT66.SGD","LU0140636845.USD","LU1226287529.USD","LU1226288170.HKD","LU0501845795.SGD","LU1813983027.USD","IE0008368742.USD","LU1152091754.HKD","LU0880133367.SGD","LU0314109678.HKD","LU0067412154.USD","SG9999004220.SGD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150603956","title":"GENFLEET-B Buys Back 50,000 Shares for HK$1.30 Million on September 15","url":"https://stock-news.laohu8.com/highlight/detail?id=1150603956","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150603956?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:52","pubTimestamp":1789465934,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) announced that on September 15, 2026, the company spent HK$1.2956 million to repurchase 50,000 of its own shares.The share buyback represents the company's ongoing commitment to...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1574","BK1515","02595","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128125870","title":"Fosun Pharma Spends HK$22.07 Million on Share Buyback on September 15","url":"https://stock-news.laohu8.com/highlight/detail?id=1128125870","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128125870?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:44","pubTimestamp":1789465484,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) made a notable market move on September 15, 2026, as the company announced the repurchase of 1.3 million of its own shares. The transaction,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK1515","HELS","BK1593","BK0060","BK0028","02196","BK0183","BK0196","BK0012","BK1191","BK0188","BK0096","600196","BK0187","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667610979","title":"CSPC Pharmaceutical Group Stock Sheds 1.9% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667610979","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667610979?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:33","pubTimestamp":1789461180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. slid 1.9% to 8.70 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.0% to 24667.24.CSPC Pharmaceutical Group Ltd. closed 21% short of its 52-week high of HK$10.96, which the company achieved Jan. 30.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 1.0%, SSY Group Ltd. rose 2.1%, and United Laboratories International Holdings Ltd. fell 2.8%.Trading volume totaled 51.4 million shares, compared to the 50-day average of 102.0 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","LU1226287529.USD","IE00BZ08YS42.EUR","IE0008368742.USD","LU0314109678.HKD","LU1226287792.SGD","LU1152091754.HKD","LU0140636845.USD","LU0072913022.USD","LU1226288170.HKD","LU2039709279.SGD","IE00BZ08YR35.GBP","IE00B5MMRT66.SGD","LU1807302812.USD","IE00B031HY20.USD","01093","LU0326950275.SGD","LU1813983027.USD","SG9999004220.SGD","HK0000165453.HKD","LU0501845795.SGD","IE0008369823.USD","LU1008478684.HKD","LU1152091168.USD","IE00B543WZ88.USD","LU1993786604.SGD","LU0067412154.USD","LU1960683339.HKD","LU1951186391.HKD","LU1226288253.USD","LU0315179316.USD","LU1226287875.USD","IE00BZ08YT58.USD","BK1521","LU0880133367.SGD","LU1328277881.USD","KURE","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667109456","title":"Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2667109456","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667109456?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:33","pubTimestamp":1789461180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 1.0% to 5.42 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.0% to 24667.24.Sino Biopharmaceutical Ltd. closed 38% below its 52-week high of HK$8.81, which the company achieved Sept. 16.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 1.9% and Amgen Inc. remained unchanged.Trading volume totaled 59.4 million shares, compared to the 50-day average of 95.3 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YS42.EUR","BIB","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU2242646821.SGD","BBH","IE00BZ08YR35.GBP","LU0058720904.USD","IE00B4R5TH58.HKD","LU2089984988.USD","LU0109394709.USD","LU1023059063.AUD","BK4585","IE0009355771.USD","BK4566","BK4534","IE00B2B36J28.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU0889565916.HKD","LU1061106388.HKD","BK1515","LU1983299246.USD","LU2112291526.USD","TBXU","HK0000165453.HKD","LU0868494617.USD","BK4139","LU1057294990.SGD","01177","IE00BZ08YT58.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","BK1191","BK1521","IE0002141913.USD","BK4533","PBE","PJP","AMGN","BK4581","LU2242652126.USD","LU1571399168.USD","BK4599","BK4588","LU0320765992.SGD","IBBQ","IBB","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667975610","title":"Alibaba Health Information Technology Stock Slides 2.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2667975610","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667975610?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:32","pubTimestamp":1789461120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Alibaba Health Information Technology Ltd. slipped 2.5% to 2.93 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.0% to 24667.24.This was the stock's second consecutive day of losses.Alibaba Health Information Technology Ltd. closed 63% below its 52-week high of HK$7.91, which the company reached Jan. 14.The stock underperformed when compared to some of its competitors, as HKT Trust & HKT Ltd. rose 0.3%.Trading volume totaled 77.2 million shares, compared to the 50-day average of 91.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSI","MHImain","09115","MCHmain","BK1584","BK1589","513600","82800","BK1591","BK1142","BK1189","03037","BK1247","BK1515","00241","83115","BK1615","07300","HK0000165453.HKD","BK1501","03115","BK1502","02800","02833","03419","HHImain","BK1571","07500","BK1610","BK1617","HSTECH","07200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151094926","title":"Shares of ALEBUND-B Surge Over 17% in Afternoon Trading on US FDA Approval for IgA Nephropathy Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1151094926","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151094926?lang=en_us&edition=fundamental","pubTime":"2026-09-15 13:58","pubTimestamp":1789451896,"startTime":"0","endTime":"0","summary":"Shares of ALEBUND-B (09637) rallied sharply in the afternoon, climbing more than 17% at one point. At the time of writing, the stock was up 12.96% to HK$25.98, with turnover reaching HK$36.28...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LABU","09637","BK4588","BK1191","159938","VXUS","09939","BK1574","BK4585","BK1515","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122495500","title":"Channel Edge Fades, Active Research Lags: Who Can Fill ICBC Credit Suisse's Equity Gap?","url":"https://stock-news.laohu8.com/highlight/detail?id=1122495500","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122495500?lang=en_us&edition=fundamental","pubTime":"2026-09-15 13:20","pubTimestamp":1789449655,"startTime":"0","endTime":"0","summary":"The greatest moat for bank-affiliated fund firms lies in distribution channels, yet in the long run, that moat only moves products, it cannot substitute for research, talent, or risk...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1515","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168074562","title":"Hong Kong Stock Flash | TYK Medicines-B (02410) Surges Over 10% as Major Shareholder's Buyback Lifts Sentiment, Following Key Drug Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1168074562","media":"Stock News","labels":["shareholding","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168074562?lang=en_us&edition=fundamental","pubTime":"2026-09-15 10:08","pubTimestamp":1789438099,"startTime":"0","endTime":"0","summary":"Shares of TYK MEDICINES-B (02410) climbed steadily higher this morning, trading up 10.1% at HK$3.38 by the time of writing, with turnover reaching HK$3.89 million.According to the latest data from...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCAI","BK1515","02410","BK4588","BK1574","09939","159938","BK4585","VXUS","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110963745","title":"GENFLEET-B (02595) Presents Encouraging Phase II Monotherapy Results for Oral KRAS G12D Inhibitor in Pretreated NSCLC at WCLC 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1110963745","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110963745?lang=en_us&edition=fundamental","pubTime":"2026-09-15 08:28","pubTimestamp":1789432097,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) has unveiled updated efficacy data from its Phase II trial evaluating GFH375 as a monotherapy for patients with pretreated KRAS G12D-mutant non-small cell lung cancer (NSCLC). The...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1515","02595","09939","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184266083","title":"Record WCLC Data From Chinese Innovators Signals Clear Recovery for CRO/CDMO Sector, Wall Street Takes Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=1184266083","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184266083?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:54","pubTimestamp":1789430067,"startTime":"0","endTime":"0","summary":"The 2026 World Conference on Lung Cancer (WCLC) taking place in Seoul from September 12-15 has become a major catalyst for Chinese innovative drug developers, with a record number of clinical data...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","BK1183","BK1191","LU1008478684.HKD","01911","LU1813983027.USD","BK1161","LNGR","IBBQ","06978","LU0140636845.USD","IE00BZ08YT58.USD","LU1951186391.HKD","BK4588","CDMO","LU1226287792.SGD","LU0501845795.SGD","IE0008369823.USD","02889","BK4139","159992","BK1515","BK1539","BK1521","LU1226288170.HKD","LU0067412154.USD","02238","SG9999004220.SGD","IE00B543WZ88.USD","HK0000165453.HKD","IE0008368742.USD","LU1152091168.USD","LU1226287875.USD","LU0315179316.USD","MEDX","LU1993786604.SGD","LU0880133367.SGD","LU0314109678.HKD","LU1226287529.USD","LU1226288253.USD","LU1152091754.HKD","IE00BZ08YS42.EUR","BK1147","BK4585","IE00BZ08YR35.GBP","KCAI","BK1574","LU1807302812.USD","LU1960683339.HKD","BK1119","LU2039709279.SGD","LU0072913022.USD","KURE","VXUS","01093","BK1144","IE00B5MMRT66.SGD","LU1328277881.USD","IE00B031HY20.USD","06871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193173717","title":"National Healthcare Security Administration Releases Roster of Pharmaceutical Firms With 'Severe' and 'Extremely Severe' Credit Violations","url":"https://stock-news.laohu8.com/highlight/detail?id=1193173717","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193173717?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:52","pubTimestamp":1789383153,"startTime":"0","endTime":"0","summary":"The Medical Price and Procurement Guidance Center, operating under the delegation of the National Healthcare Security Administration, has compiled and published a list of pharmaceutical enterprises...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","09939","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104635509","title":"Fosun Pharma Spends HK$24.7 Million Buying Back 1.455 Million Shares on September 14","url":"https://stock-news.laohu8.com/highlight/detail?id=1104635509","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104635509?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:15","pubTimestamp":1789380920,"startTime":"0","endTime":"0","summary":"Fosun Pharma (HKEX: 02196) has announced that on September 14, 2026, the company repurchased 1.455 million shares at a total cost of HK$24.7051 million.The buyback reflects the company's ongoing...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","02196","BK0187","BK1515","600196","BK0188","BK0060","BK0096","BK1593","BK0196","BK0028","BK0239","BK0175","BK0183","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180962084","title":"Market Trading Volume Shrinks as Indices Retreat; Pharma and Banking Sectors Provide Support | Huabao Fund Daily Briefing (September 14, 2026)","url":"https://stock-news.laohu8.com/highlight/detail?id=1180962084","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180962084?lang=en_us&edition=fundamental","pubTime":"2026-09-14 17:42","pubTimestamp":1789378927,"startTime":"0","endTime":"0","summary":"The domestic stock market experienced a session of reduced trading activity on Monday, with all three major indices pulling back in a volatile manner. However, downward momentum was partially...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161121","09939","BK1161","159938","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667965915","title":"CSPC Pharmaceutical Group Stock Rallies 1.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2667965915","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667965915?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:32","pubTimestamp":1789374720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. rose 1.8% to 8.87 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 24917.60.The stock's rise snapped a five-day losing streak.CSPC Pharmaceutical Group Ltd. closed 19% below its 52-week high of HK$10.96, which the company reached Jan. 30.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. rose 4.3%, SSY Group Ltd. rose 1.0%, and United Laboratories International Holdings Ltd. rose 2.3%.Trading volume totaled 95.9 million shares, compared to the 50-day average of 103.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1993786604.SGD","BK1191","IE00BZ08YS42.EUR","KURE","LU1008478684.HKD","LU1226288170.HKD","LU1226288253.USD","LU1226287792.SGD","LU0326950275.SGD","BK1515","IE00B5MMRT66.SGD","LU0140636845.USD","LU1813983027.USD","HK0000165453.HKD","LU0067412154.USD","LU2039709279.SGD","IE0008369823.USD","IE00BZ08YR35.GBP","LU1152091168.USD","LU0880133367.SGD","LU0501845795.SGD","LU1152091754.HKD","SG9999004220.SGD","IE00B543WZ88.USD","LU0072913022.USD","LU1226287529.USD","LU0315179316.USD","LU1226287875.USD","IE0008368742.USD","LU1951186391.HKD","LU1960683339.HKD","LU0314109678.HKD","BK1521","LU1807302812.USD","01093","LU1328277881.USD","IE00B031HY20.USD","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667043659","title":"BYD Electronic (International) Stock Slides 2.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2667043659","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667043659?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:32","pubTimestamp":1789374720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of BYD Electronic  Co. Ltd. shed 2.3% to 23.32 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 24917.60.This was the stock's fifth consecutive day of losses.BYD Electronic  Co. Ltd. closed 48% below its 52-week high of HK$44.60, which the company achieved Oct. 2.The stock underperformed when compared to some of its competitors, as Times Universal Group Holdings Ltd. remained unchanged.Trading volume totaled 8.8 million shares, compared to the 50-day average of 12.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1580","LU0274383008.USD","BK1149","BK1582","BK1589","00285","BK1540","LU0348766576.USD","BK1167","BK1504","LU0348767384.USD","BK1607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667659991","title":"Sino Biopharmaceutical Stock Advances 4.3% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667659991","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667659991?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:30","pubTimestamp":1789374600,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. advanced 4.3% to 5.48 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 24917.60.The stock's rise snapped a three-day losing streak.Sino Biopharmaceutical Ltd. closed 38% below its 52-week high of HK$8.86, which the company achieved Sept. 15.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 1.8% and Amgen Inc. remained unchanged.Trading volume totaled 72.9 million shares, compared to the 50-day average of 98.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","LU2112291526.USD","BK1515","PBE","LU1571399168.USD","BK4139","01177","LU2089984988.USD","BK1589","IE0009355771.USD","BK4585","LU0868494617.USD","LU0289739699.SGD","TBXU","BK4533","IE00BZ08YR35.GBP","LU0122379950.USD","BK1521","BK4588","IBB","BK4599","PJP","LU2468319806.SGD","SG9999001440.SGD","LU1057294990.SGD","AMGN","LU1061106388.HKD","LU1023059063.AUD","IE00B4R5TH58.HKD","LU0058720904.USD","IBBQ","IE00BJJMRZ35.SGD","IE00BZ08YS42.EUR","BK4581","BIB","IE00BZ08YT58.USD","BK1191","LU2242652126.USD","LU0320765992.SGD","IE0002141913.USD","BBH","LU0109394709.USD","LU1983299246.USD","IE00B2B36J28.USD","LU0889565916.HKD","BK4534","LU2242646821.SGD","HK0000165453.HKD","IE00BJT1NW94.SGD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":2,"totalSize":179,"code":"91000000","status":"200"}]}}